FFAR1 and fatty liver disease: The findings that GPR40 KO led to increased levels of FFA and cholesterol and hepatic CD36 upregulation in LDLR -deficient mice reveal a plausible mechanism by which GPR40 KO increases HFD-induced hepatic steatosis, inflammation and fibrosis.